跳至主要内容
临床试验/NCT07747142
NCT07747142尚未招募不适用

Comparaison Entre anesthésie Avec épargne Morphinique guidée Par l'Index CARDEAN® et anesthésie Sans Morphinique au Cours Des Arthroplasties Totales de Hanche : étude randomisée

Pole Sante Oreliance, Polyclinique des Longues Allees1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2026年9月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
140
试验地点
1
主要终点
Total dose of morphine required to maintain a pain score ≤ 3 on a numerical scale of 1 to 10 during the first 24 hours (dose expressed as oral morphine equivalent, OME)

研究概览

简要总结

The proposed study compares two anesthesia techniques; the hypothesis being tested is that titrating sufentanil based on the CARDEAN® index (titrated OSA) does not increase post-operative morphine consumption compared to opioid-free anesthesia (OFA). This CARDEAN®-guided titrated anesthesia approach could potentially allow for hospital discharge as early as 24 hours post-operatively and is compatible with ERAS protocols. The primary objective is to demonstrate that sufentanil administration guided by the CARDEAN® index (titrated OSA) does not increase postoperative morphine consumption compared to opioid-free anesthesia (OFA). This is a prospective, single-center, randomized, single-blind, non-inferiority study.

Two groups of 70 patients each (140 patients in total) are compared based on the type of intraoperative analgesia: titrated OSA (Arm 1) versus OFA (Arm 2).

Randomization will be performed at a 1:1 ratio and stratified by surgical approach (anterior or lateral approach).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women
  • Patient aged at least 18 years
  • Signed informed consent
  • American Society of Anesthesiologists (ASA) Class 1 to 3
  • Scheduled total hip arthroplasty under general anesthesia (anterior or lateral approach) with local analgesic infiltration performed by the surgeon at the end of the procedure
  • Affiliated with or a beneficiary of a social security scheme.

排除标准

  • ASA Class 4 or 5
  • Emergency hip surgery
  • Indication for an anesthesia technique other than general anesthesia (patient preference, benefit-risk ratio, etc.)
  • Permanent cardiac arrhythmia or permanent cardiac pacing (invalid CARDEAN® index)
  • Resting bradycardia < 50 bpm
  • Second- or third-degree atrioventricular block
  • Chronic opioid user
  • Refusal of consent
  • Patient unable to read, write, or understand French
  • Vulnerable patient as defined by Article L1121-6 of the Public Health Code (CSP)
  • Adult patient under guardianship, curatorship, or judicial protection
  • Patient unable to personally provide consent as defined by Article L.1121-8 of the CSP, or an adult under legal protection
  • Pregnant or breastfeeding woman as defined by Article L1121-5 of the CSP

研究组 & 干预措施

Titrated Opioid Sparing Anesthesia

Experimental

干预措施: Titrated Opioid Sparing Anesthesia (Procedure)

Opioid Free Anesthesia

Active Comparator

干预措施: opioid free anesthesia (Procedure)

结局指标

主要结局

Total dose of morphine required to maintain a pain score ≤ 3 on a numerical scale of 1 to 10 during the first 24 hours (dose expressed as oral morphine equivalent, OME)

时间窗: During the first 24 hours after the start of anesthesia

次要结局

  • IV morphine dose received in the PACU, expressed in MME(during the awakening)
  • Maximum pain score on a 0-10 numerical rating scale (NRS max) at rest and during movement(On postoperative days 1 and 2)
  • Stability of heart rate (HR) and mean arterial pressure (MAP)(During intervention)
  • Speed of emergence from anesthesia in the post-anesthesia care unit (PACU)(Time interval between the end of the procedure and extubation)
  • Postoperative pain control(During awakening, at day 1 and day 2 after surgery)
  • Adverse effects of postoperative opioids(During the awakening)
  • Discharge from the hospital is possible as early as 24 hours post-procedure for patients deemed eligible for early discharge (determined by the surgeon prior to the intervention).(Until 24 hours after surgery)
  • Patient satisfaction: satisfaction questionnaire (completed on the day of discharge) regarding the management of any pain.(At discharge (between 24 and 48 hours after surgery))
  • Morphine dose received in the surgical ward, expressed in MME, at 6, 12, 18, 24, 36, and 48 hours post-surgery (H0 = start of surgery)(Every 6 hours until 48 hours after surgery)
  • Number of patients not receiving morphine in the PACU(during the awakening, 24 hours after surgery, 48 hours after surgery)
  • Presence of postoperative nausea and/or vomiting (PONV)(Until up to 48 hours after surgery)
  • Acute urinary retention (defined by the presence of a bladder volume > 600 ml requiring urinary catheterization)(Until up to 48 hours after surgery)
  • Postoperative confusional state: preoperative cognitive test (Mini-Cog) and screening for postoperative confusional state (Confusion Assessment Method, CAM)(After surgery just before discharge (between 24 and 48 hours after surgery))

研究者

发起方
Pole Sante Oreliance, Polyclinique des Longues Allees
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparison Between Opioid-sparing Anesthesia Guided... | 临床试验